Summary
In this review article, recent evidence is presented that some diseases like insulin-dependent diabetes mellitus, multiple sclerosis, and idiopathic membranous nephropathy, which are primarily associated with HLA-D,DR, are also related to the rare C2, C4, and Factor B alleles. Circumstantial evidence is available that at least some of these rare variants may be functionally deficient. Based on the concept of functionally interacting gene clusters, mutant complement genes may lead to impaired effector mechanisms in virus neutralization or lysis of virus-infected cells. Other mechanisms such as alteration of vascular permeability may be involved in the development of proliferative retinopathy and familial hypertension. In lepromatous lepra, an impaired cell-mediated lysis of M. leprae may be related to the hemolytically inactive C4F1 allelic product.
Similar content being viewed by others
References
Allen FH (1974) Linkage of HL-A and GBG. Vox Sang 27: 382–384
Alper CA (1976) Inherited structural polymorphism in human C2. Evidence for genetic linkage between C2 and Bf. J Exp Med 144:1111–1115
Alper CA, Propp RP (1968) Genetic polymorphism of the third component of human complement (C'3). J Elin Invest 47:2181–2191
Alper CA, Boenisch T, Watson L (1972) Genetic polymorphism in human glycine-rich betaglycoprotein. J Exp Med 135: 68–80
Awdeh ZL, Alper CA (to be published a) Inherited polymorphism of human C4 as revealed by desialyzation. Immunobiology
Awdeh ZL, Alper CA (to be published b) Inherited structural polymorphism of the fourth component of human complement (C4). Proc Natl Acad Sci USA
Ballow M, McLean RH, Einarson M, Martin S, Yunis EJ, Dupont B, O'Neill GJ (1979) Hereditary C4 deficiency —genetic studies and linkage to HLA. Transplant Proc 11:1710–1712
Barbosa J, Weitkamp L, Guttormsen S, Johnson S, Szalapski E Jr (1979) Bf in carly-onset insulin-dependent diabetes. Lancet II:1239–1240
Batchelor JR, Morris PJ (1978) HLA and disease. In: Bodmer WF (ed) Histocompatibility testing 1977. Munksgaard, Copenhagen, pp 205–206
Bertrams J (1978) HLA and disease association. Behring Inst Mitt 62:69–92
Bertrams J, Opferkuch W, Grosse-Wilde H, Luboldt W, Schuppien W, Kuwert E (1976) C2 hypocomplementemia in multiple sclerosis. Lancet II:1358–1359
Bertrams J, Rittner Ch (to be published) Der HLA-Komplex: Immungenetische Steuerzentrale des Menschen. Dtsch Med Wochenschr
Bertrams J, Sodomann P, Grüneklee D, Gries FA (1979) Bf in early-onset insulin-dependent diabetes. Lancet II:1240
Bertrams J, Baur MP, Grüneklee D, Gries FA (to be published a) Age related association of insulin-dependent diabetes mellitus with BfF1 and the HLA-B18,BfFl linkage group. Diabetologia
Bertrams J, Dewald G, Spitznas M, Rittner Ch (to be published b) HLA-A,B,C,DR,Bf, and C2 alleles in insulin dependent diabetes mellitus with proliferative retinopathy. Immunobiology
Bertrams J, Opferkuch W, Grosse-Wilde H, Kuwert E (to be published c) HLA-Dw2-associated C2 hypocomplementemia in multiple sclerosis: A new genetic marker? In: Bauer (ed) Progress in multiple sclerosis research. Springer, New York Berlin Heidelberg, pp 371–375
Bertrams J, Sodomann P, Grosse-Wilde H, Rittner Ch (to be published d) Two HLA-B/D,DR recombinants in diabetes families: The susceptibility gene traveled with HLA-D,DR fragment. In: Terasaki PI (ed) Histocompatibility testing 1980
Bertrams J, Sodomann P, Gries FA, Sachsse B, Jahnke K (to be published e) Die HLA-Assoziation des insulinpflichtigen Typ I-Diabetes mellitus. Dtsch Med Wochenschr
Bertrams J, Stroehmann I, Mollenhauer E, Schneider M, Rittner Ch (to be published) Die HLA-DR4/Dw4-Assoziation der chronischen Polyarthritis des Erwachsenen
Bodmer WF, Parsons PA (1962) Linkage and recombination in evolution. Adv Genet 11:1–4
Bodmer WF, Bodmer JG (1978) Evolution and function of the HLA system. Br Med Bull 34:309–316
Bodmer WF (1979) Gene clusters and the HLA system. Ciba Found Symp 66:205–229
Bridges CB (1919) Duplication. Anat Rec 15:357–358
Bruun-Petersen G, Green A, Kristensen BØ, Zachariae H (1980) C4 allotypes in psoriasis, diabetes mellitus, and essential hypertension. Abstract. V. European Complement Workshop, Lund, p 35
Champsaur H, Dussaix E, Samolyk D, Fabre M, Bach Ch, Assan R (1980) Diabetes and coxsackie virus B5 infection. Lancet I:251–252
Cooper NR, Welsh RM (1979) Antibody and complement-dependent viral neutralization. Springer Semin Immunopathol 2:285–310
Dausset J, Svejgaard A (eds) (1977) HLA and disease. Munksgaard, Copenhagen
Dewald G, Rittner Ch (1979) Polymorphism of the second component of human complement (C2): Observation of the rare phenotype C2 2 (=C2 B) and data on the localization of the C2 locus in the HLA region. Vox Sang 37:47–54
Dunn LC (1954) The study of complex loci. Proc 9th Int Congr Genetics, Vol 1. Caryologia Suppl 6, p 156
Dyer PA, Klouda PT, Harris R, Mallick NT (1980) Properdin Factor B alleles in patients with idiopathic membranous nephropathy. Tissue Antigens 15:505–507
Fisher RA (1930) Genetical theory of natural selection. Oxford University Press, London
Friend P, Kim Y, Handwerger B, Reinsmoen N, Michael A, Yunis E (1975) C2 deficiency in man. Relationship, including probable genetic mapping, to the mixed lymphocyte reaction stimulator (S or LD) determinant short 7a. In: Kissmeyer-Nielsen F (ed) Histocompatibility testing 1975. Munksgaard, Copenhagen, p 928–932
Fu SM, Kunkel HG, Brusman HP, Allen FH, Fotino M (1974) Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement. J Exp Med 140:1108
Gamble DR (1976) A possible virus etiology for juvenile diabetes. In: Creutzfldt W, Köbberling J, Neel JV (eds) The genetics of diabetes mellitus. Springer, Berlin
Giles CM (1977) Serologically difficult red cell antibodies with special reference to the Chido and Rogers blood groups. In: Human blood groups. 5th International Convocation of Immunology, Buffalo, New York 1976. Karger, Basel
Giles CM, Gedde-Dahl T jr, Robson EB, Thorsby E, Olaisen B, Armason A, Kissmeyer-Nielsen F, Schreuder I (1976) Rga (Rodgers) and the HLA region: Linkage and associations. Tissue Antigens 8:143–149
Greiner J, Weber FJ, Mauff G, Baur MP (to be published) Genetic polymorphisms of properdin factor B (Bf), the second component (C2), and the fourth component (C4) of complement in leprosy patients and healthy controls from Thailand. Immunobiology
Hauptmann G, Grosshans E, Heid E (1974) Lupus érthémateux aigus et déficit héréditaire en complement. A propos d'un cas par déficit complet en C4. Ann Dermatol Syphiligr (Paris) 101:479–496
Hobart MJ, Lachmann PJ (1976a) Allotyping of complement components in whole serum by isoelectric focusing in gel followed by specific heamolytic assay. J Immunol (Abstract) 116:1736
Hobart MJ, Lachmann PJ (1976b) Allotypes of complement components in man. Transplant Rev 32:26–42
Honen J, Herva E, Tiilikainen A, Aakerblom HK, Koivukangas T, Kouvalainen K (1978) HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens 11:144–146
Joseph BS, Cooper NR, Oldstone MBA (1975) Immunologic injury of cultured cells infected with measles virus I. Role of IgG antiboby and the alternative complement pathway. J Exp Med 141:761
Kirk RL, Serjeantson SW, Theophilus J, Zimmet P, Whitehouse S, Court JM (1979) Age relationship between insulindependent diabetes mellitus and rare alleles of properdin factor B. Lancet II:537
Klemperer MR, Donaldson VH, Rosen FS (1968) Effect of C1 esterase on vascular permeability in man. J Clin Invest 47:604
Lachmann PJ, Hobart MJ (1978) Complement genetics in relation to HLA. Br Med Bull 34:247–252
Lachmann PJ (1979a) An evolutionary view of the complement system. Behring Inst Mitt 63:25–37
Lachmann PJ, Hobart MJ (1979b) The genetics of the complement system. Ciba Found Symp 66:231–250
Lamm LU, Buskjaer L, Petersen GB, Hauge M, Svejgaard A (1980) Complement C2 and C4 and factor B allotypes in insulin dependent diabetes (IDD) in Denmark. Abstract, VIIIth International Histocompatibility Conference, Los Angeles
Lewontin RC (1974) The genetic basis of evolutionary change. Columbia University Press, New York
Mahowald ML, Dalmasso AP, Petzel RA, Yunis EJ (1979) Linkage relationship of C2 deficiency, HLA and glyoxalase I loci. Vox Sang 37:321–328
Mauff G, Bender K, Fischer B (1978) Genetic polymorphism of the fourth component of human complement. Vox Sang 34:296–301
Mauff G, Adam R, Wachauf B, Hitzeroth HW, Hiller Ch (to be published) Serum concentration and functional efficiency of factor B alleles. Immunobiology
Mauff G, Federmann G, Hauptmann G (to be published b) A hemolytically inactive gene product of factor B. Immunobiology
Meo T, Atkinson J, Bernoco M, Bernoco D, Ceppellini R (1976) Mapping of the HLA locus controlling C2 structural variants and linkage disequilibrium between alleles C22 and Bw15. Eur J Immunol 6:916–919
Meo T, Atkinson JP, Bernoco M, Bernoco D, Ceppellini R (1977) Structural heterogeneity of C2 complement protein and its genetic variants in man: A new polymorphism of the HLA region. Proc Natl Acad Sci USA 74:1672–1675
Middleton J, Crookston MC, Falk JA, Robson EB, Cook, PJL, Batchelor JR, Bodmer J, Ferrara GB, Festenstein H, Harris R, Kissmeyer-Nielsen F, Lawler SD, Sachs JA, Wolf E (1974) Linkage of Chido and HLA-A. Tissue Antigens 4:366–373
Mouzon A de, Ohayon E, Ducos J, Hauptmann G (1979) Bf and C4 markers for insulin-dependent diabetes mellitus in Basques. Lancet II:1364
Neel JV, Fajans SS, Conn JW, Davidson RT (1965) Diabetes mellitus. Genetics and the epidemiology of chronic diseases. Public Health Service Publication No. 1163. Neel JV, Shaw MW, Schull WJ (eds) Government Printing Office, Washington, p 105
Nerl Ch, Grosse-Wilde H, Valet G (1977) Association of low C2 and C4 serum levels with the HLA-Dw2 allele in healthy individuals. J Exp Med 148:704–708
Nerup J, Platz P, Andersen OO, Christy M, Lyngsøe J, Poulsen JE, Ryder LP, Nielsen L, Staub, Thomsen M, Svejgaard A (1974) HL-A antigens and diabetes mellitus. Lancet II:864–866
Nerup J, Cathelineau C, Seignalet J, Thomsen M (1977) HLA and endocrine disease. In: Dausset J, Svejgaard A (eds) HLA and disease. Munksgaard, Copenhagen, p 149
Newman SL, Vogler LB, Feigin RD, Jonston RB (1978) Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B of the alternative complement pathway. N Engl J Med 299:290
Nordhagen R, Olaisen B, Teisberg P, Gedde-Dahl T jr (to be published) Association between the electrophoretically determined C4M haplotype product and partial inhibition of anti-Cha. J Immunogenetics
Ochs HD, Rosenfeld SI, Thomas ED, Giblett ED, Alper CA, Dupont B, Schaller JG, Gilliland BC, Hansen JA, Wedgwood RJ (1977) Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex. N Engl J Med 296:470–475
Ohno S (1970) Evolution by gene duplication. Springer, Berlin
Olaisen B, Teisberg P, Nordhagen R, Michaelsen T, Gedde-Dahl T Jr (1979) Human complement C4 locus is duplicated on some chromosomes. Nature 279:736
Oldstone MBA, Lampert PW (1979) Antibody mediated complement dependent lysis of virus infected cells. Springer Semin Immunopathol 2:261–283
O'Neill G, Yang SY, Tegoli J, Berger R, Dupont B (1978a) Chido and Rodgers blood groups are distinct antigenic components of human complement C4. Nature 273:668–670
O'Neill G, Yang SY, Dupont B (1979b) Two HLA-linked loci controlling the fourth compnent of human complement. Proc Natl Acad Sci USA 75:5165–5169
O'Neill GJ, Berger R, Ballow M, Yunis EJ, Dupont B (1979) Chido, Rodgers, and C4 deficiency. Transplant Proc 11:1941–1943
O'Neill GJ, Miniter P, Pollack MS, Dupont B (1980) Different HLA antigen associations for the functionally active and inactive products of the complement C4F1 allele. Fed Proc (Abstract) 39:685
Opferkuch W, Rother K, Schultz DR (eds) (1978) Clinical aspects of the complement system. Georg Thieme, Stuttgart
Platz P, Jakobsen B, Dickmeiss E, Ryder LP, Thomsen M, Svejgaard A, Nerup J, Fog T (1977) Ia and HLA-D typing of patients with multiple sclerosis (MS) and insulin-dependent diabetes (IDD). Tissue Antigens 10:192
Raum D, Glass D, Agnello V, Schur P, Alper CA (1978) Congential deficiency of C2 and factor B. N Engl J Med 299:1313
Raum D, Alper CA, Stein R, Gabbay KH (1979) Genetic marker for insulin-dependent diabetes mellitus. Lancet II:1208–1210
Rittner Ch, Hauptmann G, Grosse-Wilde H, Grosshans E, Tongio MM, Mayer S (1975) Linkage between HL-A (major histocompatibility complex) and genes controlling the synthesis of the fourth component of complement. In: Kissmeyer-Nielsen F (ed) Histocompatibility testing 1975. Munksgaard, Copenhagen, p 945–954
Rittner Ch (1976) Genetic loci of components of the classical and alternate pathway of complement activation: A new dimension of the immunogenetic linkage group (HLA) on chromosome 6 in man. Hum Genet 35:1–20
Rittner Ch, Mauff G (1978) MHC-associated complement genes in man and animals. Behring Inst Mitt 62:100–114
Rittner Ch, Zaschke S, Berghoff E, Mollenhauer E, Opferkuch W, Baur MP (to be published a) Comparative studies of human C4 phenotypes, their population genetics and association with HLA-B antigens. IIIrd Workshop on the genetics of the complement system, Cologne 1979. Immunobiology
Rittner Ch, Valentine-Thon E, Bertrams J, Grosse-Wilde H, Schneider M (to be published b) Family Bromb.: Bf and C4 gene cluster very close to HLA-D(DR). In: Terasaki PI (ed) Histocompatibility testing 1980
Rosenfeld SI, Ruddy S, Austen KF (1969) Structural polymorphism of the fourth component of human complement. J Clin Invest 48:2283–2292
Rubinstein P, Suciu-Foca N, Nicholson JF (1977) Genetics of juvenile diabetes mellitus. A recessive gene closely linked to HLA-D and with 50% penetrance. N Engl J Med 297:1036
Ryder LP, Andersen E, Svejgaard A (1979) HLA and disease registry. Third report 1979. Munksgaard, Copenhagen
Singal DP, Blajchman MA (1973) Histocompatibility (HLA-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 22:429
Spielmann RS, Baker L, Zmijewski CM (1979) Inheritance of susceptibility to juvenile onset diabetes. In: Sing CF, Skolnick (eds) Genetic analysis of common diseases: applications to predictive factors in coronary disease. Alan R. Liss, New York, p 567
Stastny P (to be published) Joint report on rheumatoid arthritis. Histocompatibility testing 1980
Suciu-Foca N, O'Neill G, Rubinstein P (to be published) Evidence for the existence of a possible Bf ‘null’ allele. Histocompatibility testing 1980
Svejgaard A, Platz P, Ryder LP, Nielsen L, Staub, Thomsen M (1975) HL-A and diseases associations—a survey. Transplant Rev 22:43
Svejgaard A, Platz P, Ryder LP (to be published) Insulindependent diabetes mellitus: Joint results of the 8th Workshop study, Histocompatibility testing 1980
Teisberg P, Akesson I, Olaisen B, Gedde-Dahl T jr, Thorsby E (1976) Genetic polymorphism of C4 in man and localization of a structural C4 locus to the HLA gene complex of chromosome 6. Nature 264:253–254
Teisberg P, Olaisen B, Gedde-Dahl T, Thorsby E, Nordhagen R (to be published a) Further investigations on the genetics of the C4 protein polymorphism. Immunobiology
Teisberg P, Olaisen B, Nordhagen R, Thorsby E, Gedde-Dahl T jr (to be published b) A haemolytically non-active C4 gene product. Immunobiology
Terasaki PI (ed) (to be published) Histocompatibility testing 1980
Thomsen G, Bodmer WF (1977) The genetic analysis of HLA and disease associations. In: Dausset J, Svejgaard A (eds) HLA and disease. Munksgaard, Copenhagen, p 84
Thomsen M, Platz P, Andersen OO, Christy M, Lyngsøe J, Nerup J, Rasmussen K, Ryder LP, Nielsen L, Staub, Svejgaard A (1975) MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev 22:125
Weidinger S, Schwarzfischer F, Cleve H (1979) Properdin factor B polymorphism. An indication for the existence of a Bf0-allele. Z Rechtsmed 83:259–264
Yoon JW, Austin M, Onodera T, Notkins AL (1979) Virusinduced diabetes mellitus. N Engl J Med 300:1173
Author information
Authors and Affiliations
Additional information
The authors' original work was supported in part by grants from Deutsche Forschungsgemeinschaft (Ri 164/14, Be 758/4, SFB 113, B3)
Rights and permissions
About this article
Cite this article
Rittner, C., Bertrams, J. On the significance of C2, C4, and factor B polymorphisms in disease. Hum Genet 56, 235–247 (1981). https://doi.org/10.1007/BF00274674
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00274674